Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test
Year: 2007
Type: article
Source: European Journal of Pharmacology
Authors: Takeo Ishiyama, Kumiko Tokuda, Tadashi Ishibashi, Akira Ito, Satoko Toma, Yukihiro Ohno
Institution: Sumitomo Dainippon Pharma (Japan)
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: lurasidone, atypical antipsychotics, MK-801, NMDA receptor antagonism, passive avoidance learning, memory consolidation, cognitive impairment in schizophrenia, dopamine D2 receptor, serotonin receptors, alpha2C-adrenoceptor, risperidone, olanzapine, quetiapine, clozapine, aripiprazole, haloperidol
Open Access status: closed
OpenAlex ID: W2023577040
